Kestra Medical Technologies, Ltd. Common Stock (KMTS) Q1 2026 Earnings
Kestra Medical Technologies, Ltd. Common Stock reported Q1 2026 revenue of $24.6M (+0.0% YoY), beat analyst consensus of $22.9M by $1.7M. Diluted EPS came in at $-0.61 (+0.0% YoY), missed the $-0.60 consensus by $0.01.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Kestra Medical Technologies, Ltd. Common Stock's Q1 2026 earnings report.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) reported Q1 2026 earnings on March 17, 2026 after market close.
Kestra Medical Technologies, Ltd. Common Stock reported revenue of $24.6M and diluted EPS of $-0.61 for Q1 2026.
Revenue beat the consensus estimate of $22.9M by $1.7M. EPS missed the consensus estimate of $-0.60 by $0.01.
Compared to the same quarter a year prior, revenue grew 0.0% from $24.6M a year earlier and diluted EPS grew 0.0% from $-0.61.
You can read the 8-K earnings release (0001193125-26-110720) and the 10-Q periodic report (0001193125-26-111205) directly on SEC EDGAR. The filing index links above go to sec.gov.